Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637520 · ClinicalTrials.gov registry record
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 29
- Enrollment target
NCT00637520 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 29 participants.
The verdict
NCT00637520 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
We hypothesize that insulin resistance is characteristic of nonalcoholic fatty liver disease as compared to age, gender, non-diabetic BMI-matched control subjects, both healthy and those with non-cirrhotic, non-steatotic liver disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2007-07 |
| Est. Completion | 2017-04-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00637520
The ClinicalTrials.gov registry entry for NCT00637520 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00637520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00637520 about?
NCT00637520 is a clinical study titled "Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study". We hypothesize that insulin resistance is characteristic of nonalcoholic fatty liver disease as compared to age, gender, non-diabetic BMI-matched control subjects, both healthy and those with non-cirrhotic, non-steatotic liver disease.
What is the current status of trial NCT00637520?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2007-07. Estimated completion is 2017-04-13.
Who is sponsoring clinical trial NCT00637520?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.